RHÖN-KLINIKUM Aktiengesellschaft

XTRA:RHK Stock Report

Market Cap: €943.8m

RHÖN-KLINIKUM Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Tobias Kaltenbach

Chief executive officer

€507.0k

Total compensation

CEO salary percentage98.6%
CEO tenure2.3yrs
CEO ownershipn/a
Management average tenure4.5yrs
Board average tenure4.5yrs

Recent management updates

Recent updates

Some Shareholders Feeling Restless Over RHÖN-KLINIKUM Aktiengesellschaft's (ETR:RHK) P/E Ratio

Jan 08
Some Shareholders Feeling Restless Over RHÖN-KLINIKUM Aktiengesellschaft's (ETR:RHK) P/E Ratio

RHÖN-KLINIKUM Aktiengesellschaft's (ETR:RHK) Business Is Trailing The Market But Its Shares Aren't

Jun 26
RHÖN-KLINIKUM Aktiengesellschaft's (ETR:RHK) Business Is Trailing The Market But Its Shares Aren't

RHÖN-KLINIKUM (ETR:RHK) Seems To Use Debt Rather Sparingly

Apr 25
RHÖN-KLINIKUM (ETR:RHK) Seems To Use Debt Rather Sparingly

RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable

Mar 02
RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable

Is RHÖN-KLINIKUM (ETR:RHK) Using Too Much Debt?

Dec 19
Is RHÖN-KLINIKUM (ETR:RHK) Using Too Much Debt?

Here's Why RHÖN-KLINIKUM (ETR:RHK) Can Manage Its Debt Responsibly

Jul 13
Here's Why RHÖN-KLINIKUM (ETR:RHK) Can Manage Its Debt Responsibly

There Are Reasons To Feel Uneasy About RHÖN-KLINIKUM's (ETR:RHK) Returns On Capital

Jun 15
There Are Reasons To Feel Uneasy About RHÖN-KLINIKUM's (ETR:RHK) Returns On Capital

These 4 Measures Indicate That RHÖN-KLINIKUM (ETR:RHK) Is Using Debt Reasonably Well

Sep 20
These 4 Measures Indicate That RHÖN-KLINIKUM (ETR:RHK) Is Using Debt Reasonably Well

Capital Allocation Trends At RHÖN-KLINIKUM (ETR:RHK) Aren't Ideal

Aug 11
Capital Allocation Trends At RHÖN-KLINIKUM (ETR:RHK) Aren't Ideal

Robust Earnings May Not Tell The Whole Story For RHÖN-KLINIKUM (ETR:RHK)

Apr 01
Robust Earnings May Not Tell The Whole Story For RHÖN-KLINIKUM (ETR:RHK)

Does RHÖN-KLINIKUM (ETR:RHK) Have A Healthy Balance Sheet?

May 14
Does RHÖN-KLINIKUM (ETR:RHK) Have A Healthy Balance Sheet?

CEO Compensation Analysis

How has Tobias Kaltenbach's remuneration changed compared to RHÖN-KLINIKUM's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

€45m

Jun 30 2024n/an/a

€47m

Mar 31 2024n/an/a

€43m

Dec 31 2023€507k€500k

€39m

Sep 30 2023n/an/a

€32m

Jun 30 2023n/an/a

€26m

Mar 31 2023n/an/a

€30m

Dec 31 2022€547k€83k

€25m

Compensation vs Market: Tobias's total compensation ($USD532.00K) is below average for companies of similar size in the German market ($USD1.40M).

Compensation vs Earnings: Tobias's compensation has been consistent with company performance over the past year.

CEO

Tobias Kaltenbach (64 yo)

2.3yrs

Tenure

€507,000

Compensation

Dr. Tobias Kaltenbach is Chief Executive Officer & Chairman of the Management Board at RHÖN-KLINIKUM Aktiengesellschaft from November 2022. Mr. Kaltenbach served as Chairman of Corporate Management at Askl...

Leadership Team

NamePositionTenureCompensationOwnership
Tobias Kaltenbach
CEO & Chairman of Management Board2.3yrs€507.00kno data
Stefan Stranz
CFO & Member of Management Board4.4yrs€543.00kno data
Gunther Weiß
COO & Member of Management Board6.8yrs€625.00kno data
Julian Schmitt
Head of Investor Relations & Treasuryno datano datano data
Eugen Münch
Chief Representative4.5yrs€219.00kno data

4.5yrs

Average Tenure

57yo

Average Age

Experienced Management: RHK's management team is considered experienced (4.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Irmtraut Gurkan
Member of Supervisory Board4.5yrs€43.00kno data
Peter Berghofer
Member of Supervisory Board14.7yrs€45.00kno data
Oliver Salomon
Member of Supervisory Board6.9yrs€34.00kno data
Christine Reißner
Member of Supervisory Board9.7yrs€33.00kno data
Hafid Rifi
Second Deputy Chairman of the Supervisory Board4.5yrs€69.00kno data
Jan Liersch
Chairman of Supervisory Board4.7yrs€102.00kno data
Peter Ducke
Member of Supervisory Board4.5yrs€39.00kno data
Regina Dickey
Member of Supervisory Board4.5yrs€45.00kno data
Thomas Pillukat
Member of Supervisory Board4.5yrs€37.00kno data
Julia Dannath-Schuh
Member of Supervisory Board4.7yrs€31.00kno data
Martin Mandewirth
Member of Supervisory Board4.5yrs€35.00kno data
Stefan Rohrhoff
First Deputy Chairman of the Supervisory Board1.1yrsno datano data

4.5yrs

Average Tenure

Experienced Board: RHK's board of directors are considered experienced (4.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/15 13:09
End of Day Share Price 2025/02/14 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

RHÖN-KLINIKUM Aktiengesellschaft is covered by 36 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Eileen RyanAlphaValue
Gerhard SchwarzBaader Helvea Equity Research
Thomas JonesBerenberg